A study of GHS-R1a internalization rates and PLC-dependent calcium flux of Ipamorelin in pituitary somatotroph models.

An in-depth, systems-level preclinical research synthesis of CJC-1295’s interaction with GHRHR and pituitary adenylate cyclase dynamics.

A detailed study on GHRH receptor Gs-protein coupling kinetics and adenylate cyclase dynamics under somatostatin challenge by CJC-1295.

Receptor Coupling Kinetics: CJC-1295 Interaction with GHRHR and Pituitary Adenylate Cyclase Dynamics

← Back to The GH Pulse Receptor Coupling Kinetics: CJC-1295 Interaction with GHRHR and Pituitary Adenylate Cyclase Dynamics Section 1: Compound Overview (Research Context Only) CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) distinguished by a covalently attached Drug Affinity Complex (DAC) moiety—specifically a maleimido-propionic acid linker. In preclinical models, this modification enables […]

Ipamorelin (chemical designation: Aib-His-D-2-Nal-D-Phe-Lys-NH2) is a synthetic pentapeptide classified as a growth hormone secretagogue (GHS) and designated for research use only (RUO).

A scientific study of GHRP-6 activation of Galphaq-PLC-IP3-Ca2+ secondary messenger signaling and pituitary somatotroph degranulation kinetics.

Investigating CJC-1295 GHRHR receptor dynamics and somatotroph secretion kinetics under physiological feedback.

An investigation into the receptor binding kinetics, internalization pathways, and somatotroph calcium signaling curves of Ipamorelin.

An exploration of CJC-1295 binding kinetics, pituitary GHRHR Gs/cAMP/PKA signaling, and tonic somatotroph stimulation without somatostatin suppression.

Characterizing Ipamorelin’s selective GHS-R1a binding dynamics and Gq-protein-mediated calcium signaling kinetics in pituitary somatotrophs.